On 16 December General Electric Company (NYSE:GE) said that it has entered an agreement to acquire the Subsea Electric Actuator product line from Oil and Gas engineering service provider, Oceaneering International (NYSE:OII). The deal is expected to be closed in the first quarter of 2015. General Electric Company (NYSE:GE) in last trading activity decreased -0.17% to close at $25.84. Company weekly performance is 5.76% while its quarterly performance stands at 2.08%. General Electric Company (NYSE:GE) is -4.76% away from its 52 week high.
Cypress Semiconductor Corporation (NASDAQ:CY) announced a cash dividend. Payment of $0.11 per share is scheduled to be paid on January 15, 2015. Shareholders who purchased CY stock prior to the ex-dividend date are eligible for the cash dividend payment. This marks the 12th quarter that CY has paid the same dividend. At the current stock price of $14.33, the dividend yield is 3.07%. On last trading day Cypress Semiconductor Corporation (NASDAQ:CY) advanced 1.81% to close at $14.61. Its volatility for the week is 2.99% while volatility for the month is 3.63%. CY’s sales growth for past 5 years was -1.10% and its EPS growth for past 5 years was 33.30%. Cypress Semiconductor Corporation (NASDAQ:CY) monthly performance is 40.21%.
Nxstage Medical, Inc (NASDAQ:NXTM) CAO Kevin Hershberger sold 8,000 shares of the company’s stock on the open market in a transaction that occurred on Monday, December 15th. The stock was sold at an average price of $17.19, for a total value of $137,520.00. Following the completion of the sale, the chief accounting officer now directly owns 18,485 shares in the company, valued at approximately $317,757. On last trading day Nxstage Medical, Inc. (NASDAQ:NXTM) increased 1.83% to close at $18.39. Its volatility for the week is 3.38% while volatility for the month is 4.21%. NXTM’s sales growth for past 5 years was 15.40% and its EPS growth for past 5 years was 24.10%. Nxstage Medical, Inc. (NASDAQ:NXTM) monthly performance is 4.43%.
On 17 December Herman Miller Inc. (NASDAQ:MLHR) reported Q2 EPS of $0.42, $0.10 worse than the analyst estimate of $0.52. Revenue for the quarter came in at $565.4 million versus the consensus estimate of $562.6 million. Herman Miller Inc. (NASDAQ:MLHR) has 0.60% insider ownership while its institutional ownership stands at 85.10%. In last trading activity company’s stock closed at $29.24.
Blonder Tongue Laboratories Inc. (NYSEMKT: BDR) VP Jeffrey W. Smith sold 23,000 shares of Blonder Tongue Labs stock on the open market in a transaction dated Thursday, December 18th. The stock was sold at an average price of $2.31, for a total transaction of $53,130.00. Blonder Tongue Laboratories Inc. (NYSEMKT: BDR) has 26.20% insider ownership while its institutional ownership stands at 6.90%. In last trading activity company’s stock closed at $2.36.